Abstract
The principles of experiment design for studies to assess the effect of therapy on acute myocardial ischemic injury are described, including ways in which such studies should be controlled for those factors which contribute to variation in infarct size. In the open-chest anesthetized dog, 90% of variation in infarct size is due to differences in the: 1) size of the vascular area at risk of infarction and, 2) volume of collateral arterial flow to this region. Although damaged by ischemia, myocytes do not die if the myocardium is reperfused with arterial blood less than 15 minutes after the onset. However, virtually all severely and moderately ischemic myocytes will be dead after six hours of ischemia have passed. The damaged myocytes die first in the subendocardium and then in a wavefront which extends out to and may include the subepicardial myocardium. In most hearts, some myocytes still are salvageable by reperfusion after being subjected to episodes of ischemia of as long as three hours.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Braunwald, E. and Sobel, B.E. In: Heart Disease. A Textbook of Cardiovascular Medicine (Ed. E. Braunwald), W.B. Saunders, Co., Philadelphia, 1988, pp. 1191–1221.
Jennings, R.B., Reimer, K.A., and Steenbergen, C., Jr. J. Mol. & Cell Cardiol. 18:769–780, 1986.
Reimer, K.A. and Jennings, R.B. Lab. Invest. 40:633–644, 1979.
Reimer, K.A. and Jennings, R.B. Circulation 60:866–876, 1979.
Jugdutt, B.I., Hutchins, G.M., Bulkley, B.H. and Becker, L.C. Circulation 60:1141–1150, 1979.
Murdock, R.H., Jr. and Cobb, F.R. Circ. Res. 47:701,-709, 1980.
Reimer, K.A., Jennings, R.B., Cobb, F.R., Murdock, R.H., Greenfield, J.C., Jr., Becker, L.C, Bulkley, B.H., Hutchins, G.M., Schwartz, R.P., Jr., Bailey, K.R., and Passamani, E.R. Circ. Res. 56:651–665, 1985.
Menick, F.J., White, F.C. and Bloor, CM. Am. Heart J. 82:503–510, 1971.
Schaper, W. In: Therapeutic Approaches to Myocardial Infarct Size Limitation (Eds. D.J. Hearse and D.M. Yellon), Raven Press, New York, 1984, pp. 79–90.
Jennings, R.B. and Reimer, K.A.: In: Enzymes in Cardiology: Diagnosis and Research (Eds. D.J Hearse and J. de Leiris), John Wiley & Sons, New York., 1979, p. 21–58.
Hugenholtz, P.G. J. Am. Coll. Cardiol. 9:1375–1384, 1987.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Jennings, R.B., Reimer, K.A. (1989). Measurement of Infarct Size: Effect of Reperfusion with Arterial Blood. In: Morganroth, J., Moore, E.N. (eds) Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents. Developments in Cardiovascular Medicine, vol 100. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1605-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1605-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8888-6
Online ISBN: 978-1-4613-1605-3
eBook Packages: Springer Book Archive